Cardiac Arrest Due to Capecitabine Toxicosis Treated With ECMO and CRRT: A Case Report

Author(s): Liqin Zhang, BM, Mingjun Liu, BM, Lutao Xie, MM, Xin Tian, MM

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 0.33

Expires Aug 01, 2027

Topics: Cardiovascular, Pharmacology, Patient Safety

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

This is the first report of a patient who developed cardiogenic shock after receiving oral chemotherapy with capecitabine and was treated with venoarterial extracorporeal membrane oxygenation combined with continuous renal replacement therapy.

Objectives

  • List three signs and symptoms of capecitabine-induced cardiotoxicity.
  • Define the role of comprehensive supportive treatments of ECMO combined with CRRT in managing capecitabine-induced cardiac arrest.
  • Emphasize patient-centered decision-making when escalating treatment modalities.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.